Cargando…
Serum macrophage inhibitory cytokine‐1 as a clinical marker for non–small cell lung cancer
The aim of this study was to investigate the value of serum macrophage inhibitory factor‐1 (MIC‐1) level in patients with non–small cell lung cancer (NSCLC). Serum samples from 296 patients with NSCLC and 240 healthy controls were collected. The levels of serum MIC‐1 were determined by ELISA. The se...
Autores principales: | Xu, Chunhua, Li, Li, Wang, Wei, Zhang, Qian, Zhang, Xiuwei, Yang, Rusong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957168/ https://www.ncbi.nlm.nih.gov/pubmed/33605059 http://dx.doi.org/10.1111/jcmm.16360 |
Ejemplares similares
-
Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2019) -
Prognostic significance of serum osteopontin levels in small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020) -
The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer
por: McKeown, D J, et al.
Publicado: (2004) -
Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020) -
In vitro and in vivo assessment of inhibitory effect of stevioside on pro-inflammatory cytokines
por: Noosud, Jatuporn, et al.
Publicado: (2017)